Valeant selects trio to fill in for ailing CEO; shares dive
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Valeant Pharmaceuticals (VRX) Bounces Day After Sharp Drop on CEO Medical Leave
December 29, 2015 9:13 AM ESTAfter dropping 10.5% Monday on news the CEO has been hospitalized with severe pneumonia and has taken an medical leave, Valeant Pharmaceuticals (NYSE: VRX) is up 1.3% this morning as investors bet on a positive outcome and see yesterday's selling as an overreaction.
... More